Investor
BIO International Convention
The world's largest biotechnology event, focusing on drug discovery partnerships, biotechnology investing, policy, and digital clinical trials.
- When
- June, Early June
- Where
- Rotating
- Format
- In person
- Organiser
- Biotechnology Innovation Organization
- Region
- Global
- Scale
- About 20,000 attendees
- Founded
- 1993
The briefing
The BIO International Convention is the global flagship event for the biotechnology industry. Organized by the Biotechnology Innovation Organization, the event is famous for its intensive business partnering system, which facilitates tens of thousands of one on one meetings between drug developers, tech providers, and investors. The conference program covers drug discovery, clinical trial technology, digital health integration, and regulatory pathways. For life science investors and healthtech operators building clinical trial platforms, it is the most critical event of the year to secure corporate partnerships.
What to expect
- Biopharma asset licensing agreements
- Clinical trial technology integration announcements
- Venture capital fund launches
- Global biotechnology intellectual property policy debates
Who is in the room
Biotech executives, pharmaceutical licensing officers, venture capitalists, digital clinical trial platform providers, and academic researchers.
Background
Founded in 1993, the convention has grown to become the massive hub of the global biotechnology ecosystem. It rotates among major US biotechnology hubs such as Boston, San Diego, and Philadelphia, reflecting the geographic concentration of life science capital.
Related events
Running this event, or spotted something out of date?